摘要
1例31岁女性为减重自行皮下注射司美格鲁肽注射液(司美格鲁肽)。3个月后体检,心电图提示窦性心动过速,实验室检查示三碘甲状腺原氨酸(T3)2.75-nmol/L、甲状腺素(T4)199.86-nmol/L、游离三碘甲状腺原氨酸(FT3)11.31-pmol/L、游离甲状腺素(FT4)46.63-pmol/L、促甲状腺激素(TSH)<0.005 mU/L。考虑为司美格鲁肽导致的窦性心动过速和甲状腺功能亢进,停用该药,给予甲巯咪唑10-mg口服、2次/d和美托洛尔25-mg口服、2次/d。治疗1个月余,患者心电图正常,复查甲状腺功能:T3-1.79-nmol/L、T4-127.33-nmol/L、FT3-4.94-pmol/L、FT4-15.87-pmol/L、TSH<0.005 mU/L。但患者出现肝酶升高:丙氨酸转氨酶327-U/L、天冬氨酸转氨酶148-U/L、γ-谷氨酰转移酶123.4-U/L。停用甲巯咪唑和美托洛尔,给予水飞蓟宾140-mg口服、3次/d和双环醇50-mg、3次/d治疗。1个月余后,患者甲状腺功能和肝功能均恢复正常,停用水飞蓟宾和双环醇。之后多次复查甲状腺功能、肝功能和心电图,均正常。
A 31-year-old woman received semaglutide injection subcutaneously for weight loss.Three months later,the electrocardiogram showed sinus tachycardia,and the laboratory tests showed triiodothyronine(T3)2.75-nmol/L,thyroxine(T4)199.86-nmol/L,free triiodothyronine(FT3)11.31-pmol/L,free thyroxine(FT4)46.63-pmol/L,thyroid-stimulating hormone(TSH)<0.005 mU/L.Considering the sinus tachycardia and hyperthyroidism caused by semaglutide injection,the drug was discontinued,and methimazole 10-mg orally,twice daily and metoprolol 25-mg orally twice daily were given.After treatment for more than 1 month,the electrocardiogram of the patient was normal,and the thyroid function examination showed T3-1.79-nmol/L,T4-127.33-nmol/L,FT3-4.94-pmol/L,FT4-15.87-pmol/L,and TSH<0.005 mU/L.However,there were elevated liver enzymes,showing alanine aminotransferase 327-U/L,aspartate aminotransferase 148-U/L,andγ-glutamyl transpeptidase 123.4-U/L.Then,methimazole and metoprolol were stopped,and silibinin 140-mg orally thrice daily combined with bicyclol 50-mg thrice daily were given.More than 1 month after treatments,the patient′s thyroid function and liver function were normal,and silibinin and bicyclol were stopped.After that,the thyroid function,liver function and electrocardiogram were all normal in repeated examinations.
作者
高玲燕
高丽华
刘桦
Gao Lingyan;Gao Lihua;Liu Hua(Department of Pharmacy,Aerospace Center Hospital,Beijing 100049,China;Department of Cardiology,Aerospace Center Hospital,Beijing 100049,China)
出处
《药物不良反应杂志》
CSCD
2024年第5期315-317,共3页
Adverse Drug Reactions Journal
基金
北京药学会2022年临床药学研究项目(LCYX-2022-21)。